Koers Scythian Biosciences Corp Canadian Securities Exchange
Aandelen
CA7840531007
Beleggingsbeheer & Fondsbeheerders
Omzet 2022 | -235,54 -322,19 -218,39 | Omzet 2023 | -31,51 -43,11 -29,22 | Marktkapitalisatie | 6,26 mln. 8,56 mln. 5,8 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -297 mln. -406 mln. -275 mln. | Nettowinst (verlies) 2023 | -34 mln. -46,51 mln. -31,52 mln. | EV/omzet 2022 | -188.347 x |
Nettoschuld 2022 | 24,76 mln. 33,87 mln. 22,96 mln. | Nettoliquiditeiten 2023 | 70,4 mln. 96,29 mln. 65,27 mln. | EV/omzet 2023 | 2.035.264 x |
K/w-verhouding 2022 |
-0,07
x | K/w-verhouding 2023 |
-0,18
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 91,99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Kania
CEO | Chief Executive Officer | - | 19-05-20 |
Deena Siblock
BRD | Director/Board Member | - | 27-02-23 |
Corporate Officer/Principal | - | 17-04-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mehdi Azodi
BRD | Director/Board Member | - | 27-02-23 |
Deena Siblock
BRD | Director/Board Member | - | 27-02-23 |
Jason Batista
BRD | Director/Board Member | - | 07-06-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,10% | 35,45 mld. | |
+14,98% | 35,8 mld. | |
0,00% | 18,37 mld. | |
+4,05% | 5,4 mld. | |
+4,58% | 3,27 mld. | |
+10,26% | 2,86 mld. | |
+19,40% | 2,85 mld. | |
-16,55% | 2,32 mld. | |
+4,02% | 1,23 mld. |